A citation-based method for searching scientific literature

T M Bryan, A Englezou, L Dalla-Pozza, M A Dunham, R R Reddel. Nat Med 1997
Times Cited: 931



T R Yeager, A A Neumann, A Englezou, L I Huschtscha, J R Noble, R R Reddel. Cancer Res 1999
Times Cited: 488




List of shared articles



Times cited

Functions of BLM Helicase in Cells: Is It Acting Like a Double-Edged Sword?
Ekjot Kaur, Ritu Agrawal, Sagar Sengupta. Front Genet 2021
0

Nuclear envelope tethering inhibits the formation of ALT-associated PML bodies in ALT cells.
Chia-Wei Yang, Meng-Hsun Hsieh, Hao-Jhe Sun, Shu-Chun Teng. Aging (Albany NY) 2021
0

ALT Positivity in Human Cancers: Prevalence and Clinical Insights.
Danny MacKenzie, Andrea K Watters, Julie T To, Melody W Young, Jonathan Muratori, Marni H Wilkoff, Rita G Abraham, Maria M Plummer, Dong Zhang. Cancers (Basel) 2021
0

TRF1 averts chromatin remodelling, recombination and replication dependent-break induced replication at mouse telomeres.
Rosa Maria Porreca, Emilia Herrera-Moyano, Eleni Skourti, Pui Pik Law, Roser Gonzalez Franco, Alex Montoya, Peter Faull, Holger Kramer, Jean-Baptiste Vannier. Elife 2020
7

SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness.
Nathaniel J Robinson, Chevaun D Morrison-Smith, Alex J Gooding, Barbara J Schiemann, Mark W Jackson, Derek J Taylor, William P Schiemann. Life Sci Alliance 2020
3


Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells.
Sevil Zencir, Meng-Hsun Hsieh, Joel-Sean Hsu, Yavuz Ergun, Guan-Ling Chou, Tsai-Kun Li, Shu-Chun Teng, Zeki Topcu. J Cancer Res Clin Oncol 2020
2

A critical role of telomere chromatin compaction in ALT tumor cell growth.
Guang Shi, Yang Hu, Xing Zhu, Yuanling Jiang, Junjie Pang, Chuanle Wang, Wenjun Huang, Yong Zhao, Wenbin Ma, Dan Liu,[...]. Nucleic Acids Res 2020
0

Protein phase separation and its role in tumorigenesis.
Shan Jiang, Johan Bourghardt Fagman, Changyan Chen, Simon Alberti, Beidong Liu. Elife 2020
3

Clinical Relevance of Alternative Lengthening of Telomeres in Cancer.
Guilherme G da Silva, Karollyne S Morais, Daniel S Arcanjo, Diêgo M de Oliveira. Curr Top Med Chem 2020
0

ALT: A Multi-Faceted Phenomenon.
Aurore Sommer, Nicola J Royle. Genes (Basel) 2020
3

Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies.
Thomas Kent, Deanne Gracias, Samuel Shepherd, David Clynes. Front Oncol 2020
7

Alternative Lengthening of Telomeres: Building Bridges To Connect Chromosome Ends.
Song My Hoang, Roderick J O'Sullivan. Trends Cancer 2020
9

Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres.
Taylor K Loe, Julia Su Zhou Li, Yuxiang Zhang, Benura Azeroglu, Michael Nicholas Boddy, Eros Lazzerini Denchi. Genes Dev 2020
17

Therapeutic Targets in Telomerase and Telomere Biology of Cancers.
Rajendra Prasad, Deeksha Pal, Wajid Mohammad. Indian J Clin Biochem 2020
1

PML Nuclear Body Biogenesis, Carcinogenesis, and Targeted Therapy.
Yuwen Li, Xiaodan Ma, Wenyu Wu, Zhu Chen, Guoyu Meng. Trends Cancer 2020
8

PML nuclear bodies and chromatin dynamics: catch me if you can!
Armelle Corpet, Constance Kleijwegt, Simon Roubille, Franceline Juillard, Karine Jacquet, Pascale Texier, Patrick Lomonte. Nucleic Acids Res 2020
6


ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition.
Dalal Bakhos-Douaihy, Chantal Desmaze, Maya Jeitany, Laurent R Gauthier, Denis Biard, Marie-Pierre Junier, Hervé Chneiweiss, François D Boussin. Oncotarget 2019
2

SLX4IP Antagonizes Promiscuous BLM Activity during ALT Maintenance.
Stephanie Panier, Marija Maric, Graeme Hewitt, Emily Mason-Osann, Himabindu Gali, Anqi Dai, Adam Labadorf, Jean-Hugues Guervilly, Philip Ruis, Sandra Segura-Bayona,[...]. Mol Cell 2019
23

Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
Flavia S Donaires, Raquel M Alves-Paiva, Fernanda Gutierrez-Rodrigues, Fernanda Borges da Silva, Maria Florencia Tellechea, Lilian Figueiredo Moreira, Barbara A Santana, Fabiola Traina, Cynthia E Dunbar, Thomas Winkler,[...]. Stem Cell Res 2019
4

ALTernative Functions for Human FANCM at Telomeres.
Beatriz Domingues-Silva, Bruno Silva, Claus M Azzalin. Front Mol Biosci 2019
6

Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells.
Mindy K Graham, Jiyoung Kim, Joseph Da, Jacqueline A Brosnan-Cashman, Anthony Rizzo, Javier A Baena Del Valle, Lionel Chia, Michael Rubenstein, Christine Davis, Qizhi Zheng,[...]. Mol Cancer Res 2019
8

Telomere clustering drives ALT.
Jaewon Min, Jerry W Shay. Aging (Albany NY) 2019
1

The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas.
Nathalie Grandin, Bruno Pereira, Camille Cohen, Pauline Billard, Caroline Dehais, Catherine Carpentier, Ahmed Idbaih, Franck Bielle, François Ducray, Dominique Figarella-Branger,[...]. Acta Neuropathol Commun 2019
2

Telomere Maintenance in Pediatric Cancer.
Sandra Ackermann, Matthias Fischer. Int J Mol Sci 2019
1

Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency.
Mingqi Han, Christine E Napier, Sonja Frölich, Erdahl Teber, Ted Wong, Jane R Noble, Eugene H Y Choi, Roger D Everett, Anthony J Cesare, Roger R Reddel. J Cell Sci 2019
10

Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells.
Kathryn E Yost, Sarah F Clatterbuck Soper, Robert L Walker, Marbin A Pineda, Yuelin J Zhu, Corbin D Ester, Soyeon Showman, Anna V Roschke, Joshua J Waterfall, Paul S Meltzer. Sci Rep 2019
14

FANCM limits ALT activity by restricting telomeric replication stress induced by deregulated BLM and R-loops.
Bruno Silva, Richard Pentz, Ana Margarida Figueira, Rajika Arora, Yong Woo Lee, Charlotte Hodson, Harry Wischnewski, Andrew J Deans, Claus M Azzalin. Nat Commun 2019
37


ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization.
Fei Li, Zhong Deng, Ling Zhang, Caizhi Wu, Ying Jin, Inah Hwang, Olga Vladimirova, Libo Xu, Lynnie Yang, Bin Lu,[...]. EMBO J 2019
16